Skip to content
10-Q

Quarterly Report

CNBX PHARMACEUTICALS INC. CNBX

0001683168-25-005075

← back to feed
Filed
Jul 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Jul 14, 2025 92.51M sh
Shares Diluted Q3 2025 · May 31, 2025 42.6M sh
Shares Diluted Q3 2025 · May 31, 2025 35.48M sh
Shares Diluted Q3 2025 · May 31, 2024 31.11M sh
Shares Diluted Q3 2025 · May 31, 2024 29.96M sh
Operating Cash Flow Q3 2025 · May 31, 2025 −$142.76K
Operating Cash Flow Q3 2025 · May 31, 2024 −$196.02K
Cash And Equivalents Q3 2025 · May 31, 2025 $13.65K
Cash And Equivalents Q3 2025 · Aug 31, 2024 $26.42K
Stockholders Equity Q3 2025 · May 31, 2025 −$2.54M
Stockholders Equity Q3 2025 · Feb 28, 2025 −$2.57M
Stockholders Equity Q3 2025 · Aug 31, 2024 −$2.48M
Stockholders Equity Q3 2025 · May 31, 2024 −$2.45M
Stockholders Equity Q3 2025 · Feb 29, 2024 −$2.36M
Stockholders Equity Q3 2025 · Aug 31, 2023 −$2.02M
Current Liabilities Q3 2025 · May 31, 2025 $2.56M
Current Liabilities Q3 2025 · Aug 31, 2024 $2.51M
Current Assets Q3 2025 · May 31, 2025 $18.62K
Current Assets Q3 2025 · Aug 31, 2024 $31.38K
Total Assets Q3 2025 · May 31, 2025 $18.62K
Total Assets Q3 2025 · Aug 31, 2024 $31.38K
Eps Diluted Q3 2025 · May 31, 2025 $0.00
Eps Diluted Q3 2025 · May 31, 2025 $0.00
Eps Diluted Q3 2025 · May 31, 2024 $0.00
Eps Diluted Q3 2025 · May 31, 2024 −$0.02
Eps Basic Q3 2025 · May 31, 2025 $0.00
Eps Basic Q3 2025 · May 31, 2025 $0.00
Eps Basic Q3 2025 · May 31, 2024 $0.00
Eps Basic Q3 2025 · May 31, 2024 −$0.02
Sga Expense Q3 2025 · May 31, 2025 $40.38K
Sga Expense Q3 2025 · May 31, 2025 $141.96K
Sga Expense Q3 2025 · May 31, 2024 $109.39K
Sga Expense Q3 2025 · May 31, 2024 $391.96K
Rd Expense Q3 2025 · May 31, 2025 $0
Rd Expense Q3 2025 · May 31, 2025 $0
Rd Expense Q3 2025 · May 31, 2024 $42.88K
Rd Expense Q3 2025 · May 31, 2024 $268.72K
Net Income Q3 2025 · May 31, 2025 −$59.73K
Net Income Q3 2025 · May 31, 2025 −$163.87K
Net Income Q3 2025 · May 31, 2024 −$130.63K
Net Income Q3 2025 · May 31, 2024 −$634.61K
Operating Income Q3 2025 · May 31, 2025 −$40.38K
Operating Income Q3 2025 · May 31, 2025 −$141.96K
Operating Income Q3 2025 · May 31, 2024 −$152.28K
Operating Income Q3 2025 · May 31, 2024 −$530.61K
Revenue Q3 2025 · May 31, 2025 $0
Revenue Q3 2025 · May 31, 2025 $0
Revenue Q3 2025 · May 31, 2024 $0
Revenue Q3 2025 · May 31, 2024 $130.07K